Showing results (31-40 of 54) with videos related to

Sort By:
Pageof 6
Blood Advances|September 14, 2020
Targeting phosphatidylinositol 3 kinase-β and -δ for Bruton tyrosine kinase resistance in diffuse large B-cell lymphomaNeeraj Jain, Satishkumar Singh, Georgios Laliotis, et al.
Experimental Hematology & Oncology|September 22, 2023
A novel CAR-T cell product targeting CD74 is an effective therapeutic approach in preclinical mantle cell lymphoma modelsWing Keung Chan, Jessica Williams, Kinnari Sorathia, et al.
JCI Insight|December 7, 2018
Training the physician-scientist: views from program directors and aspiring young investigatorsChristopher S Williams, Audra N Iness, Rebecca M Baron, et al.
Blood Advances|August 2, 2023
Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 studyBradley Haverkos, Onder Alpdogan, Robert Baiocchi, et al.
Leukemia|August 19, 2023
Exploiting the fibroblast growth factor receptor-1 vulnerability to therapeutically restrict the MYC-EZH2-CDKN1C axis-driven proliferation in Mantle cell lymphomaAnuvrat Sircar, Satishkumar Singh, Zijun Y Xu-Monette, et al.
Molecular Cancer Therapeutics|January 27, 2016
Histone Deacetylase Inhibitors Enhance the Therapeutic Potential of Reovirus in Multiple MyelomaAndrew Stiff, Enrico Caserta, Douglas W Sborov, et al.
British Journal of Haematology|July 1, 2025
Acute kidney injury after chimeric antigen receptor T-cell therapy is associated with inferior survival in patients with relapsed/refractory large B-cell lymphomaJohn Sharp, Qiuhong Zhao, Timothy J Voorhees, et al.
The Lancet. Oncology|February 3, 2024
Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein-Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trialKris Michael Mahadeo, Robert Baiocchi, Amer Beitinjaneh, et al.
Cancer|November 14, 2023
Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 StudyLakshmi Rajdev, Chia-Ching Jackie Wang, Himanshu Joshi, et al.
Blood|May 21, 2020
Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)Juan C Ramos, Joseph A Sparano, Amy Chadburn, et al.
Pageof 6